CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (7,314)	$ (1,726)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	578	760
Gain on sale of fixed assets		(5,672)
Stock-based compensation	1,525	1,707
Interest receivable	(93)	(101)
Non-cash lease expense	237	128
Loss on write-off of note receivable	2,695
Change in fair value of contingent acquisition payments	(812)	(107)
Credit losses (recoveries)	(15)	344
Increase (decrease) from changes in assets and liabilities:
Accounts receivable	648	332
Unbilled receivables	1,758	(71)
Prepaid expenses and other current assets	(613)	(406)
Tax receivable	1,361	49
Accounts payable	(359)	356
Accrued expenses	422	(628)
Deferred revenue	1,805	(7)
Net cash provided by (used in) operating activities	1,823	(5,042)
Cash flows from investing activities:
Purchases of property and equipment	(16)	(730)
Proceeds from sale of fixed assets, net		8,547
Purchases of marketable securities	(9,128)	(18,555)
Sale of marketable securities	6,000	1,250
Investment in note receivable		(2,500)
Net cash used in investing activities	(3,144)	(11,988)
Cash flows from financing activities:
Proceeds from issuance of unrestricted stock	96	154
Payments made for taxes of employees who surrendered shares related to unrestricted stock	(16)	(26)
Repurchase of common stock	(506)	(1,312)
Net cash used in financing activities	(426)	(1,184)
Decrease in cash and cash equivalents	(1,747)	(18,214)
Cash and cash equivalents, beginning of year	11,749	29,963
Cash and cash equivalents, end of year	10,002	$ 11,749
Supplemental disclosure:
Cash paid for income taxes	$ 136